U.S. Markets closed

Top Research Reports for Visa, Bank of America & Lockheed Martin

Mark Vickery
Top Research Reports for Visa, Bank of America & Lockheed Martin

Wednesday, July 24, 2019

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Visa (V), Bank of America (BAC) and Lockheed Martin (LMT). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Visa’s shares have outperformed the Zacks Financial Transaction Services industry in the past year, gaining +26.7% vs. a +23.3% increase. Visa's earnings beat expectations and grew 14% year over year, led by growth in payments volume, cross-border volume and processed transactions.

The Zacks analyst thinks numerous acquisitions and alliances plus technology upgrades and effective marketing have paved the way for long-term growth and consistent increase in revenues. The acquisition of Visa Europe is a long-term growth driver for the company. Its international business has been expanding and adds diversification benefits.

The company’s strong capital position facilitates business investments. However, high client incentives and expenses are weighing on its operating margin. Foreign exchange volatility imparts instability to the company’s earnings.

(You can read the full research report on Visa here >>>).

Shares of Bank of America have outperformed the Zacks Major Regional Banks in the year-to-date period, gaining +23.2% vs. +17.8%. The bank's earnings have surpassed expectations in each of the trailing four quarters. Its second-quarter 2019 results reflected strong consumer banking performance amid a tough operating backdrop.

The Zacks analyst thinks opening of branches in new regions, improved digital offerings, decent loan growth and efforts to control costs will aid profitability despite the Fed’s dovish monetary policy stance. Its enhanced capital deployment actions are likely to result in a strong balance sheet position.

However, dismal performance of capital markets continues to hurt the company’s investment banking and trading businesses, which in turn will hamper fee income growth. Litigation issues related to business misconduct in the pre-crisis period are likely to lead to higher legal costs.

(You can read the full research report on Bank of America here >>>).

Lockheed Martin’s shares have gained +11.7% in the past year, outperforming the Zacks Aerospace Defense industry which has gained +5.2% over the same period. Lockheed Martin ended second-quarter 2019 on an impressive note, with both earnings and revenues surpassing their respective expectations.

The Zacks analyst thinks that being the largest defense contractor in the world, the company enjoys strong demand for its high-end military equipment in domestic and international markets. As a result, it witnesses solid order growth. However, the company’s high debt-to-equity ratio shows that the stock is highly leveraged when compared with its industry.

Lockheed Martin also faces intense global competition for its broad portfolio of products and services. Additionally, suspension of the Turkish contract for the F-35 program may hurt the company’s operating results.  

(You can read the full research report on Lockheed Martin here >>>).

Other noteworthy reports we are featuring today include U.S. Bancorp (USB), Morgan Stanley (MS) and Goldman Sachs (GS).

The Hottest Tech Mega-Trend of All                

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>  

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today's Must Read

Increasing Revenues, Solid Balance Sheet Aid Visa (V)

New Branches, Digital Focus Aid BofA (BAC), Trading A Woe

Steady Order Flow to Aid Lockheed (LMT), High Leverage Ails

Featured Reports

Loan Growth Supports U.S. Bancorp (USB), Cost Woes Linger

Per Zacks analyst, U.S. Bancorp is poised to enhance interest income driven by steady growth in loans and rising interest rates. However, increasing costs are an unfavorable factor.

Goldman (GS) Exhibits Cost Control, Legal Issues Linger

Per the Zacks analyst, Goldman's cost control efforts are driving operational efficiency. Yet, legal issues and persistent weak fixed-income trading revenues remain concerns.

Wealth Management Aids Morgan Stanley (MS), Trading a Concern

Per the Zacks analyst, efforts to strengthen wealth management business and corporate lending will support Morgan Stanley. However, slump in trading and investment banking will hamper growth.

IHS Markit (INFO) Benefits From Buyouts, Debt Woes Remain

The Zacks analyst expects acquisitions to help IHS Markit expand its offerings and strengthen its international footprint.

Restructuring Aids PPG Industries (PPG), Weak Demand Ails

Per the Zacks analyst, cost savings from restructuring actions should support PPG Industries' margins.

E&P Spending Slowdown to Hit Halliburton (HAL) Earnings

The Zacks analyst is concerned that a conservative approach to capital expenditure from North American E&P operators will result in declining demand for Halliburton's services.

RPM Rides on Acquisitions & Strategic Initiatives, Costs High

Per the Zacks analyst, acquisitions and cost-saving initiatives bode well for RPM.

New Upgrades

MPLX's Andeavor Logistics Buyout to Boost Midstream Backlog

Per the Zacks analyst, MPLX will gain heavily from the Andeavor Logistics buyout, which is expected to result in increased project backlog and boost its export capabilities.

Blueprint Medicines (BPMC) Focuses on Pipeline Development

Per the Zacks analyst, Blueprint Medicines' lead candidate, avapritinib, holds great potential to treat several types of cancers. Other pipeline candidates too are progressing well.

New Investments & Cloud Growth Drive Alibaba (BABA)

Per the Zacks analyst, Alibaba continues to benefit from its strong core e-commerce business, new investments in Asia, international growth opportunities and growing cloud computing services.

New Downgrades

Exposure to Cat Loss, High Expenses Hurt W.R. Berkley (WRB)

Per the Zacks analyst, exposure to a competitive reinsurance market and rising debt, which induces high interest expenses, are major concerns. Exposure to cat loss induces underwriting volatility.

Synopsys (SNPS) Hurt By Severe Competition, Trade Tussle

Per the Zacks analyst, Synopsys is bothered by the rising competition from EDA vendors, such as Cadence Design Systems. Moreover, Sino-U.S trade spat persists as a key headwind.

Elevated Expenses, Margin Pressure to Hurt Bank OZK (OZK)

Per the Zacks analyst, higher costs due to inorganic growth efforts are likely to hurt Bank OZK's bottom-line growth to an extent. Also, continued pressure on net interest margin remains a concern.

undefined undefined
Visa Inc. (V) : Free Stock Analysis Report
U.S. Bancorp (USB) : Free Stock Analysis Report
Morgan Stanley (MS) : Free Stock Analysis Report
Lockheed Martin Corporation (LMT) : Free Stock Analysis Report
The Goldman Sachs Group, Inc. (GS) : Free Stock Analysis Report
Bank of America Corporation (BAC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research